Focal therapy for prostate cancer: A more vehement view of the approach could translate into real benefits for our patients Journal Article


Authors: Sanchez-Salas, R.; de la Rosette, J.; Polascik, T. J.; Carneiro, A.; Sivaraman, A.; Cathelineau, X.; Walz, J.
Article Title: Focal therapy for prostate cancer: A more vehement view of the approach could translate into real benefits for our patients
Abstract: The literature on focal therapy is currently insufficient to recommend it as first-line treatment. We need information from both randomised controlled trials and prospective registries for every available energy. That said, important research is under way in this field, and the door should be kept open to an approach that has the potential to offer adequate cancer control with lower morbidity and better post-treatment quality of life in properly selected patients. © 2018 European Association of Urology
Keywords: cancer growth; patient selection; diagnostic accuracy; reproducibility; consensus; editorial; practice guideline; cancer therapy; cancer hormone therapy; prostate cancer; high intensity focused ultrasound; brachytherapy; cancer control; cryoablation; photodynamic therapy; life expectancy; transrectal ultrasonography; impotence; predictive value; incontinence; tumor microenvironment; intermediate risk patient; low risk patient; gold nanoparticle; image guided biopsy; multiparametric magnetic resonance imaging; human; priority journal
Journal Title: European Urology
Volume: 74
Issue: 5
ISSN: 0302-2838
Publisher: Elsevier Science, Inc.  
Date Published: 2018-11-01
Start Page: 537
End Page: 539
Language: English
DOI: 10.1016/j.eururo.2018.04.018
PUBMED: 29724502
PROVIDER: scopus
DOI/URL:
Notes: Editorial -- Export Date: 1 November 2018 -- Source: Scopus
Altmetric Score
MSK Authors